CN103405685A - Traditional Chinese medicine composition for treating cerebrovascular disease sequelae - Google Patents
Traditional Chinese medicine composition for treating cerebrovascular disease sequelae Download PDFInfo
- Publication number
- CN103405685A CN103405685A CN2013103908663A CN201310390866A CN103405685A CN 103405685 A CN103405685 A CN 103405685A CN 2013103908663 A CN2013103908663 A CN 2013103908663A CN 201310390866 A CN201310390866 A CN 201310390866A CN 103405685 A CN103405685 A CN 103405685A
- Authority
- CN
- China
- Prior art keywords
- parts
- flos
- herba
- radix
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine composition for treating cerebrovascular disease sequelae. The traditional Chinese medicine composition is a drug prepared from the following crude drugs in parts by weight: ormosia, hawthorn, hot pepper, caltrop, pterocephalus hookeri heck, flos farfarae, flos daturae, toosendan fruit, humifuse euphorbia herb, arillus longan, semen coicis, holly bark, chingma abutilon seed, flos rosae rugosae, stalactite, sophora flower, gorgon fruit, cockscomb, teasel root, mung bean, lotus stamen, polygonum orientale, castor bean, vine of multiflower knotweed, rhododendron, seed of Chinese dodder, Chinese starjasmine stem, morinda officinalis, dandelion, cortex dictamni, platycodon grandiflorum, albizia flower, lindley eupatorium, Chinese violet, madder, radix tinosporae, rhododendron dauricum, rice-grain sprout, potentilla chinensis, herba elsholtziae, folium turpiniae, pokeberry root, lophatherum gracile, spina gleditsiae, exocarpium benincasae, nodular branch of pine, ternate buttercup root, camuning, manchurian lilac bark, and rhizoma nelumbinis. The traditional Chinese medicine composition for treating the cerebrovascular disease sequelae disclosed by the invention is reasonable in composition, and significant in effect, and can effectively treat the cerebrovascular disease sequelae.
Description
Technical field
The present invention relates to the Emergence field, relate in particular to a kind of Chinese medicine composition for the treatment of apoplexy sequela.
Background technology
Apoplexy sequela is common clinical, often accompanies hemiplegia, aphasis, facial hemiparalysis, limb adynamia or numb edema, how by due to deficiency of vital energy blood addiction, passages through which vital energy circulates retardance, controls suitable benefiting QI for activating blood circulation, the yin nourishing dredging collateral.Therefore, a kind of simple and effective Chinese medicine treatment of searching apoplexy sequela is imperative.
Summary of the invention
The purpose of this invention is to provide a kind of Chinese medicine composition for the treatment of apoplexy sequela.
In order to realize purpose of the present invention, the invention provides a kind of Chinese medicine composition for the treatment of apoplexy sequela, it is the medicament of being made by weight by following bulk drugs: 14 parts, Semen Phaseoli, 20 parts of Fructus Crataegis, 17 parts, Fructus Capsici, 5 parts of Fructus Tribulis, 2 parts of Herba pterocephali, 8 parts of Flos Farfaraees, 7 parts of Flos Daturaes, 5 parts of Fructus Toosendans, 11 parts of Herba Euphorbiae Humifusaes, 9 parts of Arillus Longans, 2 parts of Semen Coiciss, 2 parts of Cortex Ilicis Rotundaes, 7 parts of Semen Abutili, 6 parts of Flos Rosae Rugosaes, 3 parts of Stalactitums, 4 parts, Flos Sophorae, 8 parts of Semen Euryaless, 8 parts of Flos Celosiae Cristataes, 6 parts of Radix Dipsacis, 25 parts, Semen phaseoli radiati, 6 parts of Stamen Nelumbiniss, 7 parts of Fructus Polygoni Orientaliss, 2 parts of Semen Ricini, 12 parts of Caulis Polygoni Multiflori, 5 parts of Flos Rhododendri Mollis, 7 parts of Semen Cuscutae, 4 parts of Caulis Trachelospermis, 6 parts of Radix Morindae Officinaliss, 7 parts of Herba Taraxacis, 6 parts of Cortex Dictamni, 6 parts of Radix Platycodoniss, 11 parts of Flos Albiziaes, 7 parts of Herba Eupatorii Lindleyanis, 2 parts of Herba Violaes, 12 parts, Radix Rubiae, 5 parts of Radix Tinosporaes, 5 parts of Folium Rhododendri Daurici, 14 parts of Fructus Oryzae Germinatus, 16 parts of Herba Potentillae Chinensis, 5 parts of Herba Moslaes, 5 parts of leaf of Turpinia pomifera (Roxb) D O., 6 parts of Radix Phytolaccaes, 7 parts of Herba Lophatheris, 5 parts of Spina Gleditsiaes, 17 parts of Exocarpium Benincasaes, 3 parts of Pine Nodular Branchs, 5 parts of Radix Ranunculi Ternatis, 4 parts of Folium Et Cacumen Murrayae, 8 parts of 5 parts of Cortex Syingae Amurensiss and Nodus Nelumbinis Rhizomatis.
More preferably, described medicament is tablet, dispersible tablet, capsule or decoction.
The composition of the Chinese medicine composition for the treatment of apoplexy sequela of the present invention is reasonable, and successful can be treated apoplexy sequela effectively.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 decoction of the present invention
Get Semen Phaseoli 14 grams, Fructus Crataegi 20 grams, Fructus Capsici 17 grams, Fructus Tribuli 5 grams, Herba pterocephali 2 grams, Flos Farfarae 8 grams, Flos Daturae 7 grams, Fructus Toosendan 5 grams, Herba Euphorbiae Humifusae 11 grams, Arillus Longan 9 grams, Semen Coicis 2 grams, Cortex Ilicis Rotundae 2 grams, Semen Abutili 7 grams, Flos Rosae Rugosae 6 grams, Stalactitum 3 grams, Flos Sophorae 4 grams, Semen Euryales 8 grams, Flos Celosiae Cristatae 8 grams, Radix Dipsaci 6 grams, Semen phaseoli radiati 25 grams, Stamen Nelumbinis 6 grams, Fructus Polygoni Orientalis 7 grams, Semen Ricini 2 grams, Caulis Polygoni Multiflori 12 grams, Flos Rhododendri Mollis 5 grams, Semen Cuscutae 7 grams, Caulis Trachelospermi 4 grams, Radix Morindae Officinalis 6 grams, Herba Taraxaci 7 grams, Cortex Dictamni 6 grams, Radix Platycodonis 6 grams, Flos Albiziae 11 grams, Herba Eupatorii Lindleyani 7 grams, Herba Violae 2 grams, Radix Rubiae 12 grams, Radix Tinosporae 5 grams, Folium Rhododendri Daurici 5 grams, Fructus Oryzae Germinatus 14 grams, Herba Potentillae Chinensis 16 grams, Herba Moslae 5 grams, leaf of Turpinia pomifera (Roxb) D O. 5 grams, Radix Phytolaccae 6 grams, Herba Lophatheri 7 grams, Spina Gleditsiae 5 grams, Exocarpium Benincasae 17 grams, Pine Nodular Branch 3 grams, Radix Ranunculi Ternati 5 grams, Folium Et Cacumen Murrayae 4 grams, Cortex Syingae Amurensis 5 grams and Nodus Nelumbinis Rhizomatis 8 grams, add 5000 milliliters, water, and heating is 3 hours under the condition refluxed, and filters, and makes filtrate be cooled to room temperature, obtains.
Experimental example
Diagnostic criteria
Tcm diagnosis standard employing " apoplexy diagnosis and efficacy assessment standard " (Ren Zhanli, Wang Shundao. apoplexy diagnosis and efficacy assessment standard. Beijing Chinese medicine college journal, 1996,19 (1); 55-56.), Western medicine diagnose canonical reference " all kinds of diagnosis and treatment of cerebrovascular diseases main points " (Wang Xinde. all kinds of diagnosis and treatment of cerebrovascular diseases will be put Chinese Journal of Neurology, 1996,29 (6); 379-381.).
Inclusion criteria
1. cerebral thrombosis morbidity 24h, cerebral hemorrhage morbidity 48h turns out to be apoplexy sequela by head CT.Blocking part is at Basal ganglia, temporal lobe, infarction size≤18cm
2.Bleeding part is at Basal ganglia, subarachnoid space, cerebral lobe, cerebellum, amount of bleeding≤20ml; 2. Chinese medical discrimination belongs to smart empty insufficiency of blood, the resistance of deficiency of vital energy network; 3. continue toward hypertension or apoplexy medical history, minority leaves sequela.
Choose patient's 60 examples that meet above-mentioned standard, male 30 examples, female's 30 examples, 55 years old mean age.
With the decoction of preparation in embodiment 1, treat.During treatment, every day twice, each 250 milliliters, treated continuously 30 days.
Criterion of therapeutical effect
Cure: transference cure, limbs, motor function recovery, take care of oneself, and can be engaged in light work, Myodynamia recovery, focus of infarct disappears.Take a turn for the better: transference cure, the limb activity function is obviously recovered, but still stays some dysfunction, takes care of oneself, and muscular strength obviously recovers, and focus of infarct obviously absorbs.Invalid: sx↓, life needs the people to look after, and Myodynamia recovery is poor, and focus of infarct partially absorbs.
Through treatment, find 60 routine patient's transference cures, limbs, motor function recovery, take care of oneself, and can be engaged in light work, Myodynamia recovery, focus of infarct disappears, and therefore all meets the criterion of therapeutical effect of healing.
Claims (2)
1. a Chinese medicine composition for the treatment of apoplexy sequela, is characterized in that, it is the medicament of being made by weight by following bulk drugs: 14 parts, Semen Phaseoli, 20 parts of Fructus Crataegis, 17 parts, Fructus Capsici, 5 parts of Fructus Tribulis, 2 parts of Herba pterocephali, 8 parts of Flos Farfaraees, 7 parts of Flos Daturaes, 5 parts of Fructus Toosendans, 11 parts of Herba Euphorbiae Humifusaes, 9 parts of Arillus Longans, 2 parts of Semen Coiciss, 2 parts of Cortex Ilicis Rotundaes, 7 parts of Semen Abutili, 6 parts of Flos Rosae Rugosaes, 3 parts of Stalactitums, 4 parts, Flos Sophorae, 8 parts of Semen Euryaless, 8 parts of Flos Celosiae Cristataes, 6 parts of Radix Dipsacis, 25 parts, Semen phaseoli radiati, 6 parts of Stamen Nelumbiniss, 7 parts of Fructus Polygoni Orientaliss, 2 parts of Semen Ricini, 12 parts of Caulis Polygoni Multiflori, 5 parts of Flos Rhododendri Mollis, 7 parts of Semen Cuscutae, 4 parts of Caulis Trachelospermis, 6 parts of Radix Morindae Officinaliss, 7 parts of Herba Taraxacis, 6 parts of Cortex Dictamni, 6 parts of Radix Platycodoniss, 11 parts of Flos Albiziaes, 7 parts of Herba Eupatorii Lindleyanis, 2 parts of Herba Violaes, 12 parts, Radix Rubiae, 5 parts of Radix Tinosporaes, 5 parts of Folium Rhododendri Daurici, 14 parts of Fructus Oryzae Germinatus, 16 parts of Herba Potentillae Chinensis, 5 parts of Herba Moslaes, 5 parts of leaf of Turpinia pomifera (Roxb) D O., 6 parts of Radix Phytolaccaes, 7 parts of Herba Lophatheris, 5 parts of Spina Gleditsiaes, 17 parts of Exocarpium Benincasaes, 3 parts of Pine Nodular Branchs, 5 parts of Radix Ranunculi Ternatis, 4 parts of Folium Et Cacumen Murrayae, 8 parts of 5 parts of Cortex Syingae Amurensiss and Nodus Nelumbinis Rhizomatis.
2. the Chinese medicine composition for the treatment of apoplexy sequela according to claim 1, is characterized in that, described medicament is tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310390866.3A CN103405685B (en) | 2013-09-02 | 2013-09-02 | Traditional Chinese medicine composition for treating cerebrovascular disease sequelae |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310390866.3A CN103405685B (en) | 2013-09-02 | 2013-09-02 | Traditional Chinese medicine composition for treating cerebrovascular disease sequelae |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103405685A true CN103405685A (en) | 2013-11-27 |
| CN103405685B CN103405685B (en) | 2015-06-17 |
Family
ID=49598759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310390866.3A Expired - Fee Related CN103405685B (en) | 2013-09-02 | 2013-09-02 | Traditional Chinese medicine composition for treating cerebrovascular disease sequelae |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103405685B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103623096A (en) * | 2013-12-04 | 2014-03-12 | 张国显 | Reconstruction pill for treating hemiplegia and restoring consciousness and preparation method thereof |
| CN104367896A (en) * | 2014-09-30 | 2015-02-25 | 刘庆春 | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof |
| CN104784500A (en) * | 2015-05-12 | 2015-07-22 | 蒋晓云 | Medicine for treating cerebrovascular sequelae |
| CN105288442A (en) * | 2014-05-26 | 2016-02-03 | 青州市杏林春膏贴科学研究所 | Cerebral stroke preventing and treating composition containing animals, plants and fungus and mushroom Chinese herbs and preparation method of cerebral stroke preventing and treating composition |
| US10772932B2 (en) * | 2016-01-29 | 2020-09-15 | Shandong Zhonghai Pharmaceutical CO. LTD | Medicament for use in treating cardiovascular and cerebrovascular diseases |
-
2013
- 2013-09-02 CN CN201310390866.3A patent/CN103405685B/en not_active Expired - Fee Related
Non-Patent Citations (10)
| Title |
|---|
| 李向录等: "心脑血管疾病康复的单方简述 ", 《内蒙古中医药》 * |
| 李向录等: "心脑血管疾病康复的单方简述", 《内蒙古中医药》, no. 04, 31 December 2004 (2004-12-31), pages 38 * |
| 林兴栋等: "清热解毒法在中风病中的应用概况 ", 《中国民间疗法》 * |
| 林兴栋等: "清热解毒法在中风病中的应用概况", 《中国民间疗法》, vol. 10, no. 04, 30 April 2002 (2002-04-30), pages 60 - 61 * |
| 王金海: "中医治疗中风后期的点滴体会 ", 《中国乡村医药》 * |
| 王金海: "中医治疗中风后期的点滴体会", 《中国乡村医药》, vol. 16, no. 03, 31 March 2009 (2009-03-31), pages 43 - 45 * |
| 赵英霖等: "化瘀法治疗中风病探讨 ", 《山东中医杂志》 * |
| 赵英霖等: "化瘀法治疗中风病探讨", 《山东中医杂志》, vol. 25, no. 05, 31 May 2006 (2006-05-31), pages 294 - 297 * |
| 黄雄等: "出血性中风恢复期及后遗症中医药治疗的研究进展 ", 《中西医结合心脑血管病杂志》 * |
| 黄雄等: "出血性中风恢复期及后遗症中医药治疗的研究进展", 《中西医结合心脑血管病杂志》, vol. 7, no. 03, 31 March 2009 (2009-03-31), pages 339 - 341 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103623096A (en) * | 2013-12-04 | 2014-03-12 | 张国显 | Reconstruction pill for treating hemiplegia and restoring consciousness and preparation method thereof |
| CN105288442A (en) * | 2014-05-26 | 2016-02-03 | 青州市杏林春膏贴科学研究所 | Cerebral stroke preventing and treating composition containing animals, plants and fungus and mushroom Chinese herbs and preparation method of cerebral stroke preventing and treating composition |
| CN104367896A (en) * | 2014-09-30 | 2015-02-25 | 刘庆春 | Pharmaceutical composition for treating qi deficiency and blood stasis-type apoplexy and preparation method thereof |
| CN104367896B (en) * | 2014-09-30 | 2017-10-03 | 刘庆春 | A kind of pharmaceutical composition for treating Qi deficiency blood stasis type apoplexy and preparation method thereof |
| CN104784500A (en) * | 2015-05-12 | 2015-07-22 | 蒋晓云 | Medicine for treating cerebrovascular sequelae |
| US10772932B2 (en) * | 2016-01-29 | 2020-09-15 | Shandong Zhonghai Pharmaceutical CO. LTD | Medicament for use in treating cardiovascular and cerebrovascular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103405685B (en) | 2015-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103405685B (en) | Traditional Chinese medicine composition for treating cerebrovascular disease sequelae | |
| CN103083476B (en) | Traditional Chinese medicine for treating acute mastitis | |
| CN103405692B (en) | Unguent for treating erythema nodosum and preparation method thereof | |
| CN102302735A (en) | Calculus removing medicine | |
| CN102188640B (en) | Chinese medicinal damp-heat external application bag for clearing heat and detoxicating | |
| CN103656122B (en) | Chinese medicine for the treatment of fever caused by exogenous pathogenic factors and preparation method thereof | |
| CN103908602A (en) | Gynecological nursing liquid and preparation method thereof | |
| CN103845620A (en) | Traditional Chinese medicine for treating raynaud disease | |
| CN103656537B (en) | A kind of Chinese medicine for the treatment of pneumonia | |
| CN102462824A (en) | Traditional Chinese medicine used for treating lumbar disc herniation, and preparation method thereof | |
| CN102366521A (en) | Chinese herbal medicinal preparation for treating women's blood deficiency and excessive menstrual amount | |
| CN106236858A (en) | The Chinese medicine formula of a kind ofization silt the kidney invigorating | |
| CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
| CN104258299A (en) | Traditional Chinese medicine for treating mumps | |
| CN103721003A (en) | Traditional Chinese medicine preparation for treating kidney essence deficiency type pediatric hydrocephalus | |
| CN103463560A (en) | Traditional Chinese medicine composition for treating rosacea | |
| CN103099906B (en) | Traditional Chinese medicine composition for treating acute mastitis | |
| CN106421614A (en) | Spleen-invigorating, collateral-dredging and detoxifying traditional Chinese medicinal capsule | |
| CN105943639A (en) | Traditional Chinese medicine composition assisting in treating chronic subdural hematoma | |
| CN106310084A (en) | Medicine for treating rheumatism and sciatica and preparation method thereof | |
| CN106039236A (en) | Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation | |
| CN105853697A (en) | Traditional Chinese medicine preparation for treating infantile fevers and preparation method thereof | |
| CN105343777A (en) | Heart soothing pills and method for preparing same | |
| CN103933329A (en) | Traditional Chinese medicine for treating hypotension | |
| CN104398983A (en) | Formula of drug for treating diabetes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI NA Free format text: FORMER OWNER: FU RONG Effective date: 20150515 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Na Inventor after: Yu Xiu Inventor after: Yu Yanli Inventor after: Wang Cuiyu Inventor after: Yu Nini Inventor after: Wang Xinxin Inventor before: Fu Rong |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: FU RONG TO: LI NA YU XIU YU YANLI WANG CUIYU YU NINI WANG XINXIN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150515 Address after: 266200 Shandong city of Qingdao province Jimo City Lan Ao Lu No. 1281 Applicant after: Li Na Address before: 272011 emergency internal medicine, Yanzhou traditional Chinese medicine hospital, 57 West Wenhua Road, Shandong, Yanzhou Applicant before: Fu Rong |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150617 Termination date: 20160902 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |